Original language | English |
---|---|
Number of pages | 2 |
Journal | Annals of Oncology |
Volume | 30 |
Publication status | Published - Dec 2019 |
Event | Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) - Geneva, Switzerland Duration: 11 Dec 2019 → 14 Dec 2019 |
Safety and antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors: Ovarian cancer cohort data
B. Gao, J. Goh, B. Markman, M. Voskoboynik, H. K. Gan, J. Coward, D. Palmieri, J. So, T. Meniawy, C. Chen, X. Xiang, J. Qiu, Y. Xu, L. Yang, M. Millward
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review